Wells Fargo slashes price target on Fate Therapeutics Inc [FATE] – find out why.
Fate Therapeutics Inc [NASDAQ: FATE] traded at a high on Wednesday, posting a 3.54 gain after which it closed the day’ session at $4.09. The results of the trading session contributed to over 4328337 shares changing hands. Over the past one week, the price volatility